• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective.

作者信息

Díaz Luis Antonio, Arrese Marco, Arab Juan Pablo

机构信息

Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University & London Health Sciences Centre, London, ON, Canada.

出版信息

Hepatobiliary Surg Nutr. 2022 Oct;11(5):755-758. doi: 10.21037/hbsn-22-386.

DOI:10.21037/hbsn-22-386
PMID:36268241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9577997/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec17/9577997/71fe67324c46/hbsn-11-05-755-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec17/9577997/71fe67324c46/hbsn-11-05-755-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec17/9577997/71fe67324c46/hbsn-11-05-755-f1.jpg

相似文献

1
Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective.从临床和公共卫生角度看非酒精性脂肪性肝病中的肝细胞癌
Hepatobiliary Surg Nutr. 2022 Oct;11(5):755-758. doi: 10.21037/hbsn-22-386.
2
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.影响脂肪性肝炎中肝细胞癌的代谢因素。
Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.
3
Non-Alcoholic Fatty Liver Disease Progression to Non-Alcoholic Steatohepatitis-Related Primary Liver Cancer非酒精性脂肪性肝病进展为非酒精性脂肪性肝炎相关原发性肝癌
4
[Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].[非酒精性脂肪性肝病与肝细胞癌 - 2016年]
Orv Hetil. 2016 Jun 19;157(25):987-94. doi: 10.1556/650.2016.30425.
5
Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.人血管黏附蛋白-1（VAP-1）：非酒精性和酒精性脂肪性肝病中肝细胞癌的血清水平。
World J Surg Oncol. 2010 Sep 17;8:83. doi: 10.1186/1477-7819-8-83.
6
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的进行性肝纤维化。
Cells. 2021 Dec 2;10(12):3401. doi: 10.3390/cells10123401.
7
Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的肝细胞癌。
Curr Pharm Des. 2020;26(32):3909-3914. doi: 10.2174/1381612826666200429093648.
8
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.非酒精性脂肪性肝病相关肝细胞癌的特征。
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):156-164. doi: 10.1016/S2468-1253(16)30018-8. Epub 2016 Sep 8.
9
Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?对于酒精性肝病或非酒精性脂肪性肝病患者，你应该提倡进行肝细胞癌监测吗？
Clin Mol Hepatol. 2020 Apr;26(2):183-184. doi: 10.3350/cmh.2020.0042. Epub 2020 Mar 12.
10
From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.从糖到肝脂肪和公共健康：系统生物学驱动的非酒精性脂肪性肝病发病机制研究。
Proc Nutr Soc. 2019 Aug;78(3):290-304. doi: 10.1017/S0029665119000570. Epub 2019 Mar 29.

本文引用的文献

1
Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world.综述文章：全球非酒精性脂肪性肝病的流行病学负担。
Aliment Pharmacol Ther. 2022 Sep;56(6):942-956. doi: 10.1111/apt.17158. Epub 2022 Jul 26.
2
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas.美洲公共卫生政策的制定与非酒精性脂肪性肝病的负担
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):552-559. doi: 10.1016/S2468-1253(22)00008-5. Epub 2022 Apr 14.
3
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
非酒精性脂肪性肝病相关肝细胞癌的临床特征、监测、治疗分配和结局：系统评价和荟萃分析。
Lancet Oncol. 2022 Apr;23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X. Epub 2022 Mar 4.
4
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?全球非酒精性脂肪性肝病政策审查与准备指数：各国是否准备好应对这一无声的公共卫生挑战？
J Hepatol. 2022 Apr;76(4):771-780. doi: 10.1016/j.jhep.2021.10.025. Epub 2021 Dec 9.
5
Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study.非酒精性脂肪性肝病伴或不伴肝硬化的肝细胞癌：一项基于人群的研究。
BMC Gastroenterol. 2021 Oct 21;21(1):394. doi: 10.1186/s12876-021-01978-0.
6
Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.肝硬化患者肝细胞癌筛查流程的失败情况
Hepatol Commun. 2021 Sep;5(9):1481-1489. doi: 10.1002/hep4.1735. Epub 2021 May 4.
7
NAFLD: Challenges and opportunities to address the public health problem in Latin America.非酒精性脂肪性肝病：解决拉丁美洲公共卫生问题的挑战与机遇。
Ann Hepatol. 2021 Sep-Oct;24:100359. doi: 10.1016/j.aohep.2021.100359. Epub 2021 May 15.
8
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.非酒精性脂肪性肝病与肝外癌症发病风险增加：观察性队列研究的荟萃分析
Gut. 2022 Apr;71(4):778-788. doi: 10.1136/gutjnl-2021-324191. Epub 2021 Mar 8.
9
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.非酒精性脂肪性肝病中的肝细胞癌——临床医生面临的新挑战综述
Hepatobiliary Surg Nutr. 2021 Jan;10(1):59-75. doi: 10.21037/hbsn.2019.08.08.
10
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.利用多基因风险评分对非酒精性脂肪性肝病进行肝细胞癌风险的无创分层。
J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25.